Vinand Nantulya

In June 2020, the Daily Monitor reported that one of Nantulya's laboratories had designed a test for the COVID-19 virus in humans that returns results in five minutes as opposed to 45 minutes or three hours by other methods. The new testing method is undergoing the requisite regulatory approval before being subjected to mass testing in the field.

Vinand Mukatabala Nantulya, is a Ugandan physician, pathologist, medical researcher, entrepreneur and academic administrator, who since 3 October 2017, serves as the Chancellor of Busitema University, a public university in the Eastern Region of Uganda.

From 2010 until 2016, Nantulya served as Chairman of the Uganda AIDS Commission. He resigned that position in December 2016. On 3 October 2017, Professor Vinand Mukatabala Nantulya was installed as the second Chancellor of Busitema University, replacing the founding chancellor, Professor Francis Omaswa, whose ten-year service had expired.

Nantulya served on the selection committee that chose Peter Sands to succeed Mark Dybul as executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) in 2017.

After his internship at Mulago Hospital, Nantulya was employed as a teaching assistant at Makerere University School of Medicine. After his PhD studies at the University of Nairobi, he was hired as a research fellow at the International Laboratory for Research on Animal Diseases (ILRAD), in Nairobi. While there, he began lecturing at Harvard University. He became the senior research scientist in international health at the Harvard School of Public Health. He also served as a professor of health and international relations at the University of Geneva and senior fellow at the University of the Sciences in Philadelphia. In 2002 he was appointed as senior health adviser at The Global Fund to Fight AIDS, Tuberculosis and Malaria, in Geneva.

Nantulya was born on 15 January 1949 at Bulayila Village, in present-day Kibuku District, the son of Brenda Kirangi and Paulo Mukatabala.